Interactions Between p38 Mitogen-Activated Protein Kinase and Caspase-3 in Cerebral Endothelial Cell Death After Hypoxia-Reoxygenation

Stroke

Volumn 34, Issue 11, 2003, Pages 2704-2709

  Lee, Sun Ryung ^b   Lo, Eng H ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

Apoptosis; Blood brain barrier; Cerebral ischemia; Cerebrovascular disorders; Signal transduction

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CASPASE 3; CASPASE INHIBITOR; DNA FRAGMENT; LACTATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; BRAIN HYPOXIA; BRAIN ISCHEMIA; CELL PROTECTION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME RELEASE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REOXYGENATION; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS; WESTERN BLOTTING;

BRAIN; CASPASE 3; CASPASES; CELL DEATH; CELL HYPOXIA; CELL LINE; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION;

EID: 0242609993     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000096540.40826.BA     Document Type: Article

References (40)

1. Report of the Stroke Progress Review Group. National Institutes of Neurological Disorders and Stroke; 2002;1-116. Available at http://www.ninds.nih.gov/about_ninds/04_2002_Stroke_PRG_Report.htm.
2. Tagaya M, Haring HP, Stuiver I, Wagner S, Abumiya T, Lucero J, Lee P, Copeland BR, Seiffert D, del Zoppo GJ. Rapid loss of microvascular integrin expression during focal brain ischemia reflects neuron injury. J Cereb Blood Flow Metab. 2001;21:835-846.
3. Lo EH, Dalkara T, Moskowitz MA. Mechanisms, challenges, and opportunities for stroke. Nat Rev Neurosci. 2003;4:399-415.
4. Karsan A, Harlan JM. Modulation of endothelial cell apoptosis: mechanisms and pathophysiological roles. J Atheroscler Thromb. 1996;3:75-80.
5. Dimmeler S, Zeiher AM. Endothelial cell apoptosis in angiogenesis and vessel regression. Circ Res. 2000;87:434-439.
6. Mallat Z, Tedgui A. Apoptosis in the vasculature: mechanisms and functional importance. Br J Pharmacol. 2000;130:947-962.
7. Meguro T, Chen B, Lancon J, Zhang JH. Oxyhemoglobin induces caspase-mediated cell death in cerebral endothelial cells. J Neurochem. 2001;77:1128-1135.
8. Xu J, Chen S, Ku G, Ahmed SH, Xu J, Chen H, Hsu CY. Amyloid beta peptide-induced cerebral endothelial cell death involves mitochondrial dysfunction and caspase activation. J Cereb Blood Flow Metab. 2001;21:702-710.
9. Lin SH, Maiese K. The metabotropic glutamate receptor system protects against ischemic free radical programmed cell death in rat brain endothelial cells. J Cereb Blood Flow Metab. 2001;21:262-275.
10. Chang L, Karin M. Mammalian MAP kinase signaling cascades. Nature. 2001;410:37-40.
11. Nozaki K, Nishimura M, Hashimoto N. Mitogen-activated protein kinases and cerebral ischemia. Mol Neurobiol. 2001;23:1-19.
12. Robinson MJ, Cobb MH. Mitogen activated protein kinase pathways. Curr Opin Cell Biol. 1997;9:180-186.
13. Mori T, Wang X, Jung J, Sumii T, Singhal AB, Fini ME, Dixon CE, Alessandrini A, Lo EH. Mitogen activated protein kinase inhibition for traumatic brain injury: in vitro and in vivo effects. J Cereb Blood Flow Metab. 2002;22:444-452.
14. Wang X, Mori T, Jung J, Fini ME, Lo EH. Secretion of matrix metalloproteinase-2 and -9 following traumatic injury in rat cortical cultures and involvement of MAP kinase. J Neurotrauma. 2002;19:615-625.
15. Lee SR, Lo EH. Efficacy of MAP kinase inhibitors against hypoxia-reoxygenation induced cytotoxicity in human brain endothelial cells. Stroke. 2003;34:299. Abstract.
16. Utz PJ, Anderson P. Life and death decisions: regulation of apoptosis by proteolysis of signaling molecules. Cell Death Differ. 2000;7:589-602.
17. Mielke K, Herdegen T. JNK and p38 stress kinases: degenerative effectors of signal transduction cascades in the nervous system. Prog Neurobiol. 2000;61:45-60.
18. Xia Z, Dickens M, Rainegaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK/p38 MAP kinase on apoptosis. Science. 1995;270:1326-1331.
19. Le-Niculescu H, Bonfoco E, Kasuya Y, Claret F, Green DR, Karin M. Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death. Mol Cell Biol. 1999;19:751-763.
20. Minamino T, Yujiri T, Papst PJ, Chan ED, Johnson GL, Terada N. MEKK1 suppresses oxidative-stress induced apoptosis of embryonic stem cell derived cardiac myocytes. Proc Natl Acad Sci U S A. 1999;96:15127-15132.
21. Ghatan S, Lamer S, Kinoshita Y, Hetman M, Patel L, Xia Z, Youle RJ, Morrison RS. p38 MAP kinase mediates bax translocation in nitric oxide-induced apoptosis in neurons. J Cell Biol. 2000;150:335-347.
22. Sugino T, Nozaki K, Takagi Y, Hattori I, Hashimoto N, Moriguchi T, Nishida E. Activation of mitogen-activated protein kinases after transient forebrain ischemia in gerbil hippocampus. J Neurosci. 2000;20:4506-4514.
23. Roulston A, Reinhard C, Amiri P, Williams LT. Early activation of c-Jun N-terminal kinase and p38 kinase regulate cell survival in response to tumor necrosis factor alpha. J Biol Chem. 1998;273:10232-10239.
24. Alessandrini A, Namura S, Moskowitz MA, Bonventre JV. MEK1 protein kinase inhibition protects against damage from focal cerebral ischemia. Proc Natl Acad Sci U S A. 1999;96:12866-12869.
25. Mori T, Wang X, Aoki T, Lo EH. Downregulation of matrix metalloproteinase-9 and attenuation of edema via inhibition of ERK MAP kinase in traumatic brain injury. J Neurotrauma. 2002;19:1411-1419.
26. Vartiainen N, Goldsteins G, Keksa-Goldsteine V, Chan PH, Koistinaho J. Aspirin inhibits p44/42 mitogen-activated protein kinase and is protective against hypoxia/reoxygenation neuronal damage. Stroke. 2003;34:752-757.
27. Wang X, Wang H, Xu L, Rozanski DJ, Sugawara T, Chan PH, Trzaskos JM, Feuerstein GZ. Significant neuroprotection against ischemic brain injury by inhibition of the MEK1 protein kinase in mice: exploration of potential mechanism associated with apoptosis. J Pharmacol Exp Ther. 2003;304:172-178.
28. Cardier JE, Erickson-Miller CL. Fas (CD95)- and tumor necrosis factor-mediated apoptosis in liver endothelial cells: role of caspase-3 and the p38 MAPK. Microvasc Res. 2002;63:10-18.
29. Li AE, Ito H, Rovira II, Kim KS, Takeda K, Yu ZY, Ferrans VJ, Finkel T. A role for reactive oxygen species in endothelial cell anoikis. Circ Res. 1999;85:304-310.
30. Ho FM, Liu SH, Liau CS, Huang PJ, Lin-Shiau SY. High glucose-induced apoptosis in human endothelial cells is mediated by sequential activations of c-Jun NH(2)-terminal kinase and caspase-3. Circulation. 2000;101:2618-1624.
31. McGuire TF, Trump DL, Johnson CS. Vitamin D(3)-induced apoptosis of murine squamous cell carcinoma cells: selective induction of caspase-dependent MEK cleavage and up-regulation of MEKK-1. J Biol Chem. 2001;276:26365-26373.
32. Xu S, Cobb MH. MEKK1 binds directly to the c-Jun N-terminal kinases/stress-activated protein kinases. J Biol Chem. 1997;272:32056-32060.
33. Cardone MH, Salvesen GS, Widmann C, Johnson G, Frisch SM. The regulation of anoikis: MEKK-1 activation requires cleavage by caspases. Cell. 1997;90:315-323.
34. Widmann C, Gerwins P, Johnson NL, Jarpe MB, Johnson GL. MEK kinase 1, a substrate for DEVD-directed caspases, is involved in genotoxin-induced apoptosis. Mol Cell Biol. 1998;18:2416-2429.
35. Hess DC, Howard E, Cheng C, Carroll J, Hill WD, Hsu CY. Hypertonic mannitol loading of NF-kappaB transcription factor decoys in human brain microvascular endothelial cells blocks upregulation of ICAM-1. Stroke. 2000;31:1179-1186.
36. Xu J, Wu Y, He L, Yang Y, Moore SA, Hsu CY. Regulation of cytokine-induced iNOS expression by a hairpin oligonucleotide in murine cerebral endothelial cells. Biochem Biophys Res Commun. 1997;235:394-397.
37. Davies SP, Reddy H, Caivano M, Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J. 2000;351:95-105.
38. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W, Leisten JC, Motiwala A, Pierce S, Satoh Y, et al. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci U S A. 2001;98:13681-13686.
39. Graham SH, Chen I. Programmed cell death in cerebral ischemia. J Cereb Blood Flow Metab. 2001;21:99-109.
40. Lin SH, Maiese K. Group I metabotropic glutamate receptors prevent endothelial programmed cell death independent from MAP kinase p38 activation in rat. Neurosci Lett. 2001;298:207-211.